Position in ABUS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,764,916
+$2,791,790 QoQ
Shares Held
4,117,691
+9.2% QoQ
Ownership
2.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ABUS ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ABUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,764,916 | 4,117,691 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,973,126 | 3,771,806 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,687,846 | 3,677,307 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $16,644,374 | 3,666,162 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,238,394 | 3,637,021 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $12,358,596 | 3,541,145 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,386,583 | 3,482,136 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,277,109 | 3,448,600 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,237,658 | 3,313,158 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,633,928 | 2,958,887 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,044,237 | 2,817,695 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,475,080 | 2,697,084 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,975,689 | 2,598,126 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,932,376 | 2,287,913 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,965,854 | 2,131,268 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,838,794 | 2,009,840 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,837,463 | 1,785,042 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,155,334 | 1,729,978 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,494,837 | 1,669,624 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,608,448 | 1,540,431 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,898,573 | 1,286,658 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,780,158 | 534,582 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,425,861 | 401,651 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,190,580 | 380,377 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $569,714 | 313,030 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $109,479 | 108,396 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||